| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.052 | 0.5 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.04 | 0.5 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |